The approved proposal for raising of funds.
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech's Board, at its meeting on December 10, 2025, approved a proposal to raise up to Rs. 150 Crores through equity shares and/or convertible or non-convertible securities. The company may use methods such as public issue, rights issue, preferential allotment, private placement, or Qualified Institutions Placement (QIP), in one or more tranches. The price and timing will be decided later, and shareholder approval will be sought separately. No specific use of funds, investor names, pricing, or instrument details have been disclosed at this stage.
This is a preliminary approval and does not yet trigger dilution or any concrete fundraising. Shareholders should wait for further updates on the chosen mode, pricing, and end-use, which will determine whether the raise is dilutive and how it affects the stock.